Get the Stockscreener App
18.36
0.92%
-0.17
Pre-market:
18.96
0.60
+3.27%
Fulgent Genetics Inc stock is traded at $18.36, with a volume of 529.26K.
It is down -0.92% in the last 24 hours and down -8.47% over the past month.
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.
See More
Previous Close:
$18.53
Open:
$18.56
24h Volume:
529.26K
Relative Volume:
1.72
Market Cap:
$558.94M
Revenue:
$290.71M
Net Income/Loss:
$-163.43M
P/E Ratio:
-3.3504
EPS:
-5.48
Net Cash Flow:
$11.70M
1W Performance:
+1.89%
1M Performance:
-8.47%
6M Performance:
+12.09%
1Y Performance:
-26.74%
1-Day Range:
$17.53
$18.56
1-Week Range:
$16.98
$19.51
52-Week Range:
$14.76
$25.00
Fulgent Genetics Inc Stock (FLGT) Company Profile
Name
Fulgent Genetics Inc
Sector
Industry
Phone
626-350-0537
Address
4399 SANTA ANITA AVE, EL MONTE
Compare FLGT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
FLGT
Fulgent Genetics Inc
|
18.36 | 567.19M | 290.71M | -163.43M | 11.70M | -5.48 |
|
TMO
Thermo Fisher Scientific Inc
|
466.57 | 174.85B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
197.46 | 141.13B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
682.78 | 43.07B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
114.84 | 32.24B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
182.75 | 31.02B | 15.50B | 1.33B | 2.16B | 7.34 |
Fulgent Genetics Inc Stock (FLGT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-07-23 | Initiated | UBS | Neutral |
| Dec-08-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Nov-18-22 | Initiated | Raymond James | Outperform |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Feb-04-22 | Resumed | Piper Sandler | Overweight |
| Aug-05-21 | Resumed | Credit Suisse | Underperform |
| Jan-08-21 | Downgrade | Credit Suisse | Neutral → Underperform |
| Nov-24-20 | Downgrade | BTIG Research | Buy → Neutral |
| Aug-20-20 | Initiated | Oppenheimer | Outperform |
| May-29-20 | Initiated | BTIG Research | Buy |
| Nov-05-19 | Upgrade | Piper Jaffray | Neutral → Overweight |
| Mar-01-18 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Nov-07-17 | Downgrade | Raymond James | Outperform → Mkt Perform |
View All
Fulgent Genetics Inc Stock (FLGT) Latest News
Fulgent Genetics stock rating upgraded to Buy at UBS on growth potential - Investing.com Canada
Fulgent Genetics lifts 2025 revenue outlook to $320M and narrows EPS loss guidance while advancing clinical pipeline - MSN
Fulgent Genetics (NASDAQ:FLGT) Announces Quarterly Earnings Results - MarketBeat
Fulgent Genetics, Inc. (NASDAQ:FLGT) Shares Sold by Bank of New York Mellon Corp - MarketBeat
Published on: 2025-08-04 03:43:28 - Jammu Links News
When is Fulgent Genetics Inc. stock expected to show significant growthDiscover market opportunities with expert help - Jammu Links News
What analysts say about Fulgent Genetics Inc. stockDiscover hidden gems in the stock market - Jammu Links News
Is Fulgent Genetics Inc. a growth stock or a value stockAchieve remarkable returns with smart investing - Jammu Links News
Fulgent Genetics Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
How does Fulgent Genetics Inc. generate profit in a changing economyTrack emerging stocks with high growth potential - Jammu Links News
What institutional investors are buying Fulgent Genetics Inc. stockUnlock exclusive investment alerts - Jammu Links News
How strong is Fulgent Genetics Inc. company’s balance sheetGet real-time alerts on high-potential stocks - Jammu Links News
Should I hold or sell Fulgent Genetics Inc. stock in 2025Unlock expert stock analysis and alerts - Jammu Links News
What makes Fulgent Genetics Inc. stock price move sharplyExplosive returns - Jammu Links News
What is the dividend policy of Fulgent Genetics Inc. stockCapitalize on momentum-driven opportunities - Jammu Links News
Fulgent Genetics (NASDAQ:FLGT) Shares Gap Up After Earnings Beat - MarketBeat
Fulgent Genetics (NASDAQ:FLGT) Issues FY 2025 Earnings Guidance - MarketBeat
Fulgent Genetics, Inc. (NASDAQ:FLGT) Q2 2025 Earnings Call Transcript - Insider Monkey
Fulgent (FLGT) Q2 Revenue Jumps 16% - The Globe and Mail
Fulgent Genetics Inc (FLGT) Q2 2025 Earnings Call Highlights: Strong Core Revenue Growth Amid ... - Yahoo Finance
GSA Capital Partners LLP Acquires 85,481 Shares of Fulgent Genetics, Inc. (NASDAQ:FLGT) - MarketBeat
Fulgent Genetics Reports Strong Core Revenue Growth - TipRanks
Fulgent Genetics 2025 Q2 Earnings Revenue Surges 15.2% as Losses Widen - AInvest
What are analysts’ price targets for Fulgent Genetics Inc. in the next 12 monthsChart Pattern Planner With Low Risk - Jammu Links News
Why Fulgent Genetics Stock Was Crushing It on Friday - The Motley Fool
Why Fulgent Genetics Stock Was Crushing It on Friday - Nasdaq
Fulgent Reports Second Quarter 2025 Financial Results - BioSpace
Fulgent Genetics Tops Expectations But Still Faces Losses - Finimize
Earnings call transcript: Fulgent Genetics Q2 2025 exceeds revenue forecast, stock surges - Investing.com India
Earnings call transcript: Fulgent Genetics Q2 2025 exceeds revenue forecast, stock surges By Investing.com - Investing.com South Africa
Fulgent Genetics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Fulgent Genetics Q2 2025 slides: Revenue up 16% YoY, shares surge 13.5% - Investing.com Canada
Fulgent Genetics Soars 16.41% on Strong Q2 Earnings - AInvest
Fulgent Genetics, Inc. (FLGT) Surpasses Q2 Earnings and Revenue Estimates - Yahoo Finance
Fulgent Genetics Soars 16.47% on Strong Q2 Earnings - AInvest
Fulgent Genetics Soars 10.59% on Q2 Revenue Growth - AInvest
Fulgent Genetics' Q2 2025 Earnings Beat and Strategic Momentum Signal a Re-rating Opportunity - AInvest
Fulgent Genetics earnings beat by $0.25, revenue topped estimates - Investing.com Canada
Fulgent Genetics, Inc. SEC 10-Q Report - TradingView
Fulgent Genetics Inc. Earnings Report Breakdown: What Investors Should KnowTen-Year Sector Performance and Summary Analysis - Newser
Fulgent Genetics Inc. Forms Bullish Flag — Upside AheadLow Risk Swing Trade Opportunities Identified - metal.it
Why Fulgent Genetics Inc. stock attracts strong analyst attentionSecure Return Focused Investment Plan Released - beatles.ru
Is Fulgent Genetics Inc. a Top Dividend Stock to Watch in 2025Real-Time Trade Insights Spark Market Reactions - metal.it
Y Intercept Hong Kong Ltd Invests $1.05 Million in Fulgent Genetics, Inc. (NASDAQ:FLGT) - MarketBeat
Fulgent Genetics (FLGT) Expected to Announce Earnings on Friday - MarketBeat
Is Fulgent Genetics Inc. Stock a Smart Buy in 2025 Investment Analysis Inside High Accuracy Trade Setup Identification - metal.it
What are the latest earnings results for Fulgent Genetics Inc.Capitalize on market trends with confidence - Jammu Links News
Fulgent Genetics Inc Stock (FLGT) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.63%
1.48%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):